IFN-inducible chemokines, known as CXCR3 ligand chemokines [11], have been recognized as anti-tumor chemokines in mouse tumor models and clinicopathological analyses of human solid tumors [15,16,17,18,19,20,21,22,23,24,25]. This evidence concerns the gene CXCR3 and neoplasm.